There are 3161 resources available
1125P - Accuracy of PET-CT to assess extent of nodal disease in clinical stage III melanoma
Presenter: Ronen Stoff
Session: Poster session 04
1126P - A phase II study of nivolumab/relatlimab in metastatic uveal melanoma
Presenter: Jose Lutzky
Session: Poster session 04
1127P - Subgroup analysis of FOCUS phase III trial efficacy results
Presenter: Matthew Wheater
Session: Poster session 04
1128P - Preliminary results of first-in-human study of 225-Actinium MTI-201 (225Ac-MTI-201) in metastatic uveal melanoma
Presenter: Nikhil Khushalani
Session: Poster session 04
1129P - Clinical outcomes from a tebentafusp UK expanded access program in patients with metastatic uveal melanoma (mUM)
Presenter: Paul Nathan
Session: Poster session 04
1130P - Phase II trial on nivolumab plus radiotherapy in patients with metastatic mucosal melanoma: PORTER-M3 trial
Presenter: Motoo Nomura
Session: Poster session 04
1131P - A phase II study of pembrolizumab combination with temozolomide as 1L treatment for Chinese metastatic acral melanoma patients
Presenter: Ya Ding
Session: Poster session 04
1132P - Regorafenib in Caucasian patients with pretreated advanced KIT-mutant melanoma: A dual center case series
Presenter: Iris Dirven
Session: Poster session 04
1133P - Only early adjuvant radiotherapy, particularly of the tumor bed rather than the lymph node region, improves prognosis in Merkel cell carcinoma: Results from the prospective German MCC registry
Presenter: Juergen Becker
Session: Poster session 04
1134P - Avelumab in metastatic Merkel cell carcinoma (mMCC): Conditional survival and long-term safety in patients treated for ≥1 or ≥2 years in JAVELIN Merkel 200
Presenter: Celeste Lebbe
Session: Poster session 04